Target Validation Information
Target ID T98933
Target Name Thyroid hormone receptor beta-1
Target Type
Successful
Drug Potency against Target 1-(4-hexylphenyl)-3-(propylamino)propan-1-one Drug Info IC50 = 15200 nM [529081]
4-(4-hexylphenyl)-4-oxobut-2-enoic acid Drug Info IC50 = 17700 nM [529081]
Detrothyronine Drug Info IC50 = 0.26 nM [527923]
MB-07811 Drug Info Ki = 2.95 nM [529784]
(4-hexylphenyl)(oxiran-2-yl)methanone Drug Info IC50 = 19100 nM [529081]
(Z)-4-(4-hexylphenylamino)-4-oxobut-2-enoic acid Drug Info IC50 = 17900 nM [529081]
(E)-1-(4-heptylphenyl)but-2-en-1-one Drug Info IC50 = 7600 nM [529081]
4-hexylphenyl propiolate Drug Info IC50 = 6200 nM [529081]
3-(3,5-Dibromo-4-hexyloxy-phenyl)-propionic acid Drug Info IC50 = 1000 nM [527532]
2-hexylphenyl acrylate Drug Info IC50 = 8200 nM [529081]
3-(dimethylamino)-1-(4-hexylphenyl)propan-1-one Drug Info IC50 = 4300 nM [529081]
4-(3-(Dimethylamino)propanoyl)-N-hexylbenzamide Drug Info IC50 = 8100 nM [530166]
3-(dimethylamino)-1-(4-heptylphenyl)propan-1-one Drug Info IC50 = 9600 nM [530166]
1-(4-(Hexyloxy)phenyl)-3-morpholinopropan-1-one Drug Info IC50 = 4100 nM [530166]
(3,5-Dibromo-4-butoxy-phenyl)-acetic acid Drug Info IC50 = 1900 nM [527532]
3-(dibutylamino)-1-(4-hexylphenyl)propan-1-one Drug Info IC50 = 4200 nM [529081]
1-(4-octylphenyl)prop-2-en-1-one Drug Info IC50 = 11400 nM [529081]
1-(4-heptylphenyl)prop-2-en-1-one Drug Info IC50 = 10500 nM [529081]
1-(4-hexylphenyl)-3-morpholinopropan-1-one Drug Info IC50 = 2700 nM [529081]
(3,5-Dibromo-4-pentyloxy-phenyl)-acetic acid Drug Info IC50 = 5700 nM [527532]
3-bromo-1-(4-hexylphenyl)propan-1-one Drug Info IC50 = 3000 nM [529081]
(3,5-Dibromo-4-hexyloxy-phenyl)-acetic acid Drug Info IC50 = 800 nM [527532]
3-(4-(benzyloxy)-3,5-dibromophenyl)propanoic acid Drug Info IC50 = 230 nM [528640]
References
Ref 529081J Med Chem. 2007 Nov 1;50(22):5269-80. Epub 2007 Oct 5.Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Ref 529081J Med Chem. 2007 Nov 1;50(22):5269-80. Epub 2007 Oct 5.Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Ref 527923Bioorg Med Chem Lett. 2006 Mar 1;16(5):1240-4. Epub 2005 Dec 9.Thyroid receptor ligands. Part 5: novel bicyclic agonist ligands selective for the thyroid hormone receptor beta.
Ref 529784J Med Chem. 2008 Nov 27;51(22):7075-93.Synthesis and biological evaluation of a series of liver-selective phosphonic acid thyroid hormone receptor agonists and their prodrugs.
Ref 529081J Med Chem. 2007 Nov 1;50(22):5269-80. Epub 2007 Oct 5.Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Ref 529081J Med Chem. 2007 Nov 1;50(22):5269-80. Epub 2007 Oct 5.Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Ref 529081J Med Chem. 2007 Nov 1;50(22):5269-80. Epub 2007 Oct 5.Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Ref 529081J Med Chem. 2007 Nov 1;50(22):5269-80. Epub 2007 Oct 5.Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Ref 527532J Med Chem. 2005 May 5;48(9):3114-7.Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor.
Ref 529081J Med Chem. 2007 Nov 1;50(22):5269-80. Epub 2007 Oct 5.Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Ref 529081J Med Chem. 2007 Nov 1;50(22):5269-80. Epub 2007 Oct 5.Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Ref 530166J Med Chem. 2009 Jul 9;52(13):3892-901.Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.
Ref 530166J Med Chem. 2009 Jul 9;52(13):3892-901.Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.
Ref 530166J Med Chem. 2009 Jul 9;52(13):3892-901.Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.
Ref 527532J Med Chem. 2005 May 5;48(9):3114-7.Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor.
Ref 529081J Med Chem. 2007 Nov 1;50(22):5269-80. Epub 2007 Oct 5.Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Ref 529081J Med Chem. 2007 Nov 1;50(22):5269-80. Epub 2007 Oct 5.Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Ref 529081J Med Chem. 2007 Nov 1;50(22):5269-80. Epub 2007 Oct 5.Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Ref 529081J Med Chem. 2007 Nov 1;50(22):5269-80. Epub 2007 Oct 5.Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Ref 527532J Med Chem. 2005 May 5;48(9):3114-7.Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor.
Ref 529081J Med Chem. 2007 Nov 1;50(22):5269-80. Epub 2007 Oct 5.Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Ref 527532J Med Chem. 2005 May 5;48(9):3114-7.Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor.
Ref 528640Bioorg Med Chem Lett. 2007 Apr 1;17(7):2018-21. Epub 2007 Jan 13.Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.